Menopause News

Women who use contraceptive pills may be at a higher risk for frontal fibrosing alopecia, according to a study.

Regardless of socioeconomic status, menopause symptom severity was associated with race and ethnicity, highlighting differences in symptom experiences, according to study results published in Menopause.

BOSTON — Menopause is a neurologic transition involving metabolic and immune systems of the brain, and timely estrogen therapy could reduce the risk for developing dementias and other neurogenerative diseases, according to a speaker.

In this Healio video exclusive, a speaker at the National Lipid Association Scientific Sessions discusses opportunities for heart disease prevention in women at the time of menopause transition.

Results of Women’s Health Initiative trials highlight the importance of personalized health care in combination with shared decision-making for postmenopausal women, according to a review published in JAMA.

SAN FRANCISCO — Health care providers must combat menopause misinformation on social media by providing evidence-based information at visits and on online platforms, according to presenters at the ACOG Annual Clinical & Scientific Meeting.

Acute increases in physical activity were associated with greater odds of objective and subjective hot flashes during waking and sleeping periods, according to findings published in Menopause.

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.

SAN FRANCISCO — In two phase 3 trials, the nonhormonal investigational agent elinzanetant was associated with decreased frequency and severity of menopausal vasomotor symptoms over 12 weeks with a favorable safety profile.

Postmenopausal women assigned daily oral lasofoxifene had significant and clinically meaningful improvements in vulvovaginal atrophy symptoms with a favorable safety profile, researchers reported in Menopause.